A
Avalo Therapeutics D
D
AVTX
4.73000
USD
-0.14
(-2.87%)
مفتوح الان
حجم التداول
2,271
الربح لكل سهم
-5
العائد الربحي
-
P/E
0
حجم السوق
51,214,643
العنوان: Avalo Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).